структура |
наименование химического вещества |
Номер CAS |
молекулярная формула |
![Lisinopril Cyclohexyl Analog](/CAS/20150408/GIF/1132650-67-9.gif) |
Lisinopril Cyclohexyl Analog |
1132650-67-9 |
C21H37N3O5 |
![4'-(pyrimidin-2-ylsulphamoyl)acetanilide](/CAS/GIF/127-74-2.gif) |
4'-(pyrimidin-2-ylsulphamoyl)acetanilide |
127-74-2 |
C12H12N4O3S |
![LevetiracetaM IMpurity B](/CAS/20180808/GIF/358629-47-7.gif) |
LevetiracetaM IMpurity B |
358629-47-7 |
C8H12N2O2 |
![LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE)](/CAS/GIF/6538-82-5.gif) |
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE) |
6538-82-5 |
C7H13ClNO2 |
![Cetirizine Ethyl Ester (USP RC A)](/CAS/20150408/GIF/246870-46-2.gif) |
Cetirizine Ethyl Ester (USP RC A) |
246870-46-2 |
C23H29ClN2O3 |
![1-Cyano-3-isopropylguanidine](/CAS2/GIF/44830-55-9.gif) |
1-Cyano-3-isopropylguanidine |
44830-55-9 |
C5H10N4 |
![MAIZE POWDER MA 1.0 IRMM CERTIFIED RE-F](/) |
MAIZE POWDER MA 1.0 IRMM CERTIFIED RE-F |
68525-86-0 |
|
![Dalasetron (Мезилат гидрат)](/CAS/20210111/GIF/878143-33-0.gif) |
Dalasetron (Мезилат гидрат) |
878143-33-0 |
C20H24N2O6S |
![Boric acid (isotope ratio)](/) |
Boric acid (isotope ratio) |
|
|
![Iron-56Fe solution](/CAS/20200401/GIF/CB92097564.gif) |
Iron-56Fe solution |
|
Fe |
![CALCIUM ASCORBATE - REFERENCE SPECTRUM](/) |
CALCIUM ASCORBATE - REFERENCE SPECTRUM |
|
|
![Ranitidine Resolution Mixture](/CAS/20150408/GIF/CB92714865.gif) |
Ranitidine Resolution Mixture |
|
C13H22N4O3S |
![Chloroquine Related CoMpound E](/CAS/20180808/GIF/5428-61-5.gif) |
Chloroquine Related CoMpound E |
5428-61-5 |
C18H26ClN3 |
![Copper-65Cu solution](/CAS/20200401/GIF/CB72092792.gif) |
Copper-65Cu solution |
|
Cu |
![FLUMAZENIL - REFERENCE SPECTRUM](/) |
FLUMAZENIL - REFERENCE SPECTRUM |
|
|
![HEPARIN LOW-MOLECULAR-MASS FOR CALIBRATION CRS](/) |
HEPARIN LOW-MOLECULAR-MASS FOR CALIBRATION CRS |
|
|
![Abacavir StereoisoMers Mixture](/) |
Abacavir StereoisoMers Mixture |
|
|
![Hemoglobin HbA0 (non-glycated)](/) |
Hemoglobin HbA0 (non-glycated) |
|
|
![Megestrol Acetate IMpurity K](/) |
Megestrol Acetate IMpurity K |
|
|
![MeloxicaM Related CoMpound D](/) |
MeloxicaM Related CoMpound D |
|
|
![CHLORAMPHENICOL DISODIUM DISUCCINATE](/StructureFile/ChemBookStructure22/GIF/CB0587578.gif) |
CHLORAMPHENICOL DISODIUM DISUCCINATE |
|
C19H20Cl2N2Na2O13-2 |
![3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride](/CAS/20200119/GIF/CB12541748.gif) |
3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride |
|
C32H40ClNO4 |
![EUROSOIL 5](/) |
EUROSOIL 5 |
|
|
![OXOLINIC ACID IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB2587895.gif) |
OXOLINIC ACID IMPURITY A |
26893-27-6 |
C11H7NO5 |
![CLOSANTEL SODIUM DIHYDRATE](/) |
CLOSANTEL SODIUM DIHYDRATE |
|
|
![3-[3-(diMethylaMino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate](/CAS/20200119/GIF/CB32541601.gif) |
3-[3-(diMethylaMino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
|
C22H21FN2O6 |
![Anastrozole iMpurity E](/) |
Anastrozole iMpurity E |
|
|
![CitalopraM Related CoMpound G](/) |
CitalopraM Related CoMpound G |
|
|
![Levothyroxine for Peak Identification](/) |
Levothyroxine for Peak Identification |
|
|
![Orlistat Related CoMpound E](/) |
Orlistat Related CoMpound E |
|
|
![Pharmaceutical glass containers (Alkali leaching and release)](/) |
Pharmaceutical glass containers (Alkali leaching and release) |
|
|
![Lithium carbonate-7Li](/) |
Lithium carbonate-7Li |
|
7Li2CO3 |
![Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione)](/CAS/20200515/GIF/160596-25-8.gif) |
Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) |
160596-25-8 |
C18H17N3O3S |
![DIPHENOXYLATE HYDROCHLORIDE - REFERENCE SPECTRUM](/) |
DIPHENOXYLATE HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
![TIAPRIDE N-OXIDE](/CAS/20200611/GIF/63484-11-7.gif) |
TIAPRIDE N-OXIDE |
63484-11-7 |
C15H24N2O5S |
![ACECLOFENAC - REFERENCE SPECTRUM](/) |
ACECLOFENAC - REFERENCE SPECTRUM |
|
|
![POLYGLYCERYL-3 DIISOSTEARATE](/) |
POLYGLYCERYL-3 DIISOSTEARATE |
66082-42-6 |
C45H88O9 |
![Silicon (isotope ratio)](/) |
Silicon (isotope ratio) |
|
|
![Triprolidine Hydrochloride Z-IsoMer](/CAS/20180808/GIF/51657-91-1.gif) |
Triprolidine Hydrochloride Z-IsoMer |
51657-91-1 |
C19H23ClN2 |
![RETINOL ESTERS](/) |
RETINOL ESTERS |
|
|
![OXFENDAZOLE WITH IMPURITY D](/) |
OXFENDAZOLE WITH IMPURITY D |
|
|
![Vitamin D Assay System Suitability](/) |
Vitamin D Assay System Suitability |
|
|
![Boron-11B solution](/CAS/20200401/GIF/CB72097353.gif) |
Boron-11B solution |
|
BH3 |
![Platinum (isotope ratio)](/) |
Platinum (isotope ratio) |
|
|
![Pyrantel Related CoMpound A](/) |
Pyrantel Related CoMpound A |
|
|
![ALLOPURINOL IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB7587522.gif) |
ALLOPURINOL IMPURITY A |
|
C5H4N4O |
![Vancomycin B with Monodechlorovancomycin](/) |
Vancomycin B with Monodechlorovancomycin |
|
|
![TICARCILLIN IMPURITY A](/CAS/20180808/GIF/6933-26-2.gif) |
TICARCILLIN IMPURITY A |
6933-26-2 |
C13H12OS |
![TYLOSIN PHOSPHATE FOR PEAK IDENTIFICATION](/) |
TYLOSIN PHOSPHATE FOR PEAK IDENTIFICATION |
|
|
![Cefoperazone dihydrate](/CAS/20180713/GIF/113826-44-1.gif) |
Cefoperazone dihydrate |
113826-44-1 |
C25H29N9O9S2 |
![Темазепам примесь G (15 мг) (7-хлор-1,4-диметил-5-фенил-4,5-дигидро-1H-1,4-бензодиазепин-2,3-дион)](/CAS/20180808/GIF/93329-92-1.gif) |
Темазепам примесь G (15 мг) (7-хлор-1,4-диметил-5-фенил-4,5-дигидро-1H-1,4-бензодиазепин-2,3-дион) |
93329-92-1 |
C17H15ClN2O2 |
![Flutrimazole carbinol](/CAS/20150408/GIF/128092-72-8.gif) |
Flutrimazole carbinol |
128092-72-8 |
C19H14F2O |
![HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM](/) |
HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM |
|
|
![82999, 237NpO2 (V encapsulated)](/CAS/GIF/58670-16-9.gif) |
82999, 237NpO2 (V encapsulated) |
58670-16-9 |
NpO2 |
![Medroxyprogesterone Acetate Related CoMpound A](/) |
Medroxyprogesterone Acetate Related CoMpound A |
|
|
![EUROSOIL 2](/) |
EUROSOIL 2 |
|
|
![AMIODARONE IMPURITY D](/) |
AMIODARONE IMPURITY D |
|
|
![DIPHENHYDRAMINE IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB0587462.gif) |
DIPHENHYDRAMINE IMPURITY A |
|
C17H21NO |
![TRANS-EPOXYPHYTOMENADIONE](/) |
TRANS-EPOXYPHYTOMENADIONE |
|
|
![Cefprozil Related CoMpound K](/) |
Cefprozil Related CoMpound K |
|
|
![PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM](/) |
PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
![Abacavir Related CoMpound D](/CAS/20180808/GIF/1443421-69-9.gif) |
Abacavir Related CoMpound D |
1443421-69-9 |
C18H21ClN10O |
![Enrofloxacin Related CoMpound Mixture](/) |
Enrofloxacin Related CoMpound Mixture |
|
|
![DICLAZURIL FOR VETERINARY USE - REFERENCE SPECTRUM](/) |
DICLAZURIL FOR VETERINARY USE - REFERENCE SPECTRUM |
|
|
![TRICLOSAN RELATED COMPOUNDS MIXTURE A (1.2 ML/AMPULE; 3 AMPULES)](/) |
TRICLOSAN RELATED COMPOUNDS MIXTURE A (1.2 ML/AMPULE; 3 AMPULES) |
|
|
![picotamide monohydrate](/CAS/GIF/80530-63-8.gif) |
picotamide monohydrate |
80530-63-8 |
|
![EUROSOIL 4](/) |
EUROSOIL 4 |
|
|
![Human serum (high creatinine)](/) |
Human serum (high creatinine) |
|
|
![Fluticasone Propionate Resolution Mixture](/CAS/20150408/GIF/CB32714777.gif) |
Fluticasone Propionate Resolution Mixture |
|
C28H35F3O6S |
![EUROSOIL 1](/) |
EUROSOIL 1 |
|
|
![96946-42-8](/CAS/GIF/96946-42-8.gif) |
96946-42-8 |
96946-42-8 |
|
![Cadmium-111Cd solution](/CAS/20200119/GIF/CB42096805.gif) |
Cadmium-111Cd solution |
|
Cd |
![OseltaMivir IMpurity A](/CAS/20180906/GIF/1364932-19-3.gif) |
OseltaMivir IMpurity A |
1364932-19-3 |
C14H24N2O4 |
![LaMivudine Resolution Mixture C](/) |
LaMivudine Resolution Mixture C |
|
|
![METHYLTHIONINIUM IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB4587844.gif) |
METHYLTHIONINIUM IMPURITY A |
1231958-32-9 |
C16H18N3S+ |
![1-(3,4-dichlorophenyl)-5-isopropylbiguanide monohydrochloride](/CAS/GIF/6001-93-0.gif) |
1-(3,4-dichlorophenyl)-5-isopropylbiguanide monohydrochloride |
6001-93-0 |
C11H16Cl3N5 |
![SalMeterol Resolution Check](/CAS/20150408/GIF/CB52714872.gif) |
SalMeterol Resolution Check |
|
C25H37NO4 |
![IFOSFAMIDE IMPURITY E](/CAS/20200611/GIF/42453-19-0.gif) |
IFOSFAMIDE IMPURITY E |
42453-19-0 |
C5H11Cl2N |
![PANCREAS POWDER (PROTEASE) BRP](/) |
PANCREAS POWDER (PROTEASE) BRP |
|
|
![GENOMIC DNA OF ESCHERICHIA COLI O157 (EDL 933)](/) |
GENOMIC DNA OF ESCHERICHIA COLI O157 (EDL 933) |
|
|
![GMO Standard ERM-BF411, Maize Bt-176](/) |
GMO Standard ERM-BF411, Maize Bt-176 |
|
|
![Темазепам примесь F (15 мг) (7-хлор-1-метил-5-фенил-4,5-дигидро-1H-1,4-бензодиазепин-2,3-дион)](/CAS/20180808/GIF/3294-96-0.gif) |
Темазепам примесь F (15 мг) (7-хлор-1-метил-5-фенил-4,5-дигидро-1H-1,4-бензодиазепин-2,3-дион) |
3294-96-0 |
C16H13ClN2O2 |
![EUROSOIL 3](/) |
EUROSOIL 3 |
|
|
![CeftazidiMe, Delta-3-IsoMer](/) |
CeftazidiMe, Delta-3-IsoMer |
|
|
![Fosinopril Related CoMpound F](/) |
Fosinopril Related CoMpound F |
|
|
![OMeprazole Related CoMpound F and G Mixture](/) |
OMeprazole Related CoMpound F and G Mixture |
|
|
![SulfaMethoxazole Related CoMpound F](/CAS/20180808/GIF/17103-52-5.gif) |
SulfaMethoxazole Related CoMpound F |
17103-52-5 |
C10H11N3O3S |
![IFOSFAMIDE IMPURITY B](/CAS/20180808/GIF/241482-18-8.gif) |
IFOSFAMIDE IMPURITY B |
241482-18-8 |
C10H24Cl2N2O7P2 |
![Lamivudine Resolution Mixture B](/) |
Lamivudine Resolution Mixture B |
|
|
![Вориконазол](/CAS/GIF/137234-62-9.gif) |
Вориконазол |
137234-62-9 |
C16H14F3N5O |
![Rubidium-85Rb solution](/CAS/20200401/GIF/CB82098418.gif) |
Rubidium-85Rb solution |
|
Rb |
![Cefadroxil Related CoMpound I](/CAS/20180808/GIF/147103-94-4.gif) |
Cefadroxil Related CoMpound I |
147103-94-4 |
C16H17N3O5S |
![Cefprozil Related CoMpound H](/) |
Cefprozil Related CoMpound H |
|
|
![TRIMETHOPRIM IMPURITY B](/) |
TRIMETHOPRIM IMPURITY B |
|
|
![GMO Standard ERM-BF412, Maize Bt-11](/) |
GMO Standard ERM-BF412, Maize Bt-11 |
|
|
![(S)-1-(3-((ethyl(methyl)carbamoyl)oxy)phenyl)-N,N-dimethylethanamine](/CAS/GIF/415973-05-6.gif) |
(S)-1-(3-((ethyl(methyl)carbamoyl)oxy)phenyl)-N,N-dimethylethanamine |
415973-05-6 |
C14H22N2O2 |
![MetaMizole iMpurity E](/) |
MetaMizole iMpurity E |
|
|
![GalantaMine HydrobroMide Related CoMpounds Mixture](/) |
GalantaMine HydrobroMide Related CoMpounds Mixture |
|
|
![ENDOTOXIN STANDARD](/) |
ENDOTOXIN STANDARD |
|
|
![POTASSIUM CLAVULANATE - REFERENCE SPECTRUM](/) |
POTASSIUM CLAVULANATE - REFERENCE SPECTRUM |
|
|